Track the 파마리서치바이오 stock price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are listed on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 파마리서치바이오 has published 11 reports. Market capitalisation: €128.4bn. The latest transaction was filed on 4 March 2026 (Sale). Among the most active insiders: 신한캐피탈. All data is free.
11
Insider Decl.
n/a
Thresholds
n/a
3 ops.
Buy Volume
n/a
7 ops.
Sell Volume
2Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 4,661 of 29,063 companies
69.3
score / 100
Value
62
Quality
77
FCF yld-0.9%
Earn yld9.6%
EV/EBITDA9.4x
ROE·
Gross mgn70%
Net mgn40%
Debt/EBITDA2.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.